Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

When Will Gilead Make Its M&A Move?

Pills

Related Content

ViiV’s Visibility Grows And Pressure Mounts For What Comes Next

Apr 04 2016

Gilead: Three HIV Launches Expected In Near-Term Future

Oct 28 2015

With Parity Pricing, Gilead Relies On <em>Genvoya</em> Safety To Convert From <em>Stribild</em>

Nov 06 2015

Gilead Not Bullet-Proof After All: Harvoni US Sales Tumble More Than 50%

Apr 28 2016

Related Companies

Gilead Sciences, Inc.

Galapagos NV

Gilead Sciences, Inc.

Additional Topics

Commercial Business Strategies Deals Infectious Diseases BioPharmaceutical

More from Business

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window